Portfolio (Quarterly)
Guide ↗
Bellevue Group AG
· CIK 0001674546| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | NTRA | NATERA INC | Healthcare | 31,694.0 | $6.3M | 0.15% | -24K | -43.4% | $199.99 | +1.9% |
| 42 | INSP | INSPIRE MED SYS INC | Healthcare | 99,735.0 | $5.1M | 0.12% | -1K | -1.0% | $51.58 | -13.3% |
| 43 | PRVA | PRIVIA HEALTH GROUP INC | Healthcare | 226,703.0 | $4.7M | 0.11% | -221K | -49.4% | $20.57 | +12.7% |
| 44 | PEN | PENUMBRA INC | Healthcare | 12,267.0 | $4.0M | 0.10% | -123K | -90.9% | $328.37 | -0.1% |
| 45 | ILMN | ILLUMINA INC | Healthcare | 20,223.0 | $2.5M | 0.06% | -3K | -11.8% | $123.26 | +17.5% |
| 46 | OMDA | OMADA HEALTH INC | Healthcare | 157,938.0 | $2.0M | 0.05% | -20K | -11.2% | $12.57 | +30.8% |
| 47 | BNTX | BIONTECH SE | Healthcare | 20,851.0 | $1.9M | 0.04% | -23K | -52.4% | $88.88 | +2.3% |
| 48 | SPY | STATE STR SPDR S&P 500 ETF T | Financial Services | 2,700.0 | $1.8M | 0.04% | -400.0 | -12.9% | $650.34 | +14.2% |
| 49 | INSM | INSMED INC | Healthcare | 10,034.0 | $1.6M | 0.04% | -4K | -27.9% | $163.52 | -33.0% |
| 50 | MASI | MASIMO CORP | Healthcare | 8,753.0 | $1.6M | 0.04% | -89K | -91.0% | $177.87 | +0.4% |
| 51 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 14,447.0 | $1.5M | 0.04% | -2K | -12.7% | $105.40 | -4.3% |
| 52 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 2,077.0 | $1.2M | 0.03% | -2K | -46.7% | $592.98 | -4.9% |
| 53 | PHR | PHREESIA INC | Healthcare | 130,992.0 | $1.1M | 0.03% | -52K | -28.5% | $8.38 | +5.6% |
| 54 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 76,181.0 | $1.1M | 0.03% | -222K | -74.4% | $13.88 | -0.1% |
| 55 | BMY | BRISTOL-MYERS SQUIBB CO | Healthcare | 17,038.0 | $1.0M | 0.03% | -50K | -74.6% | $60.65 | -1.8% |
| 56 | EHC | ENCOMPASS HEALTH CORP | Healthcare | 9,829.0 | $951K | 0.02% | -9K | -48.5% | $96.73 | +8.0% |
| 57 | — | NEWAMSTERDAM PHARMA COMPANY | — | 27,661.0 | $885K | 0.02% | -9K | -23.9% | $32.01 | — |
| 58 | LEGN | LEGEND BIOTECH CORP | Healthcare | 35,886.0 | $649K | 0.01% | -28K | -43.9% | $18.09 | +54.7% |
| 59 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 4,646.0 | $612K | 0.01% | -1.7M | -99.7% | $131.74 | +18.0% |
| 60 | CYTK | CYTOKINETICS INC | Healthcare | 8,841.0 | $583K | 0.01% | -384.0 | -4.2% | $65.91 | +18.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.2%
Energy
0.1%
Financial Services
0.1%
Consumer Cyclical
0.0%
Communication Services
0.0%
Consumer Defensive
0.0%